Scientists hope to give people back the use of disabled arms and legs after a world-first breakthrough allowing them to regrow the missing nerves in rats.
Trials of the technology are still in the early stages, but better-than-expected results raise prospects of saving limbs lost in accidents or eventually overcoming paraplegia and quadriplegia.
St Vincent’s Hospital researchers have built and implanted a bridge between severed nerves in areas too large and complex to be healed by conventional nerve grafts.
After successfully restoring the feeling and partial use of legs in rats missing the main nerve to their limbs, director of neurosciences Prof Mark Cook said new trials had begun to see how far the technology can allow nerves to regrow in the hope it can be expanded to humans studies in the next two to five years.
“We will have the potential to deal with a broader range and bigger injured nerves down the track,” Prof Cook said.
“Some of these gaps in humans are substantial. You can have long sections of nerves in humans because obviously their limbs are a lot longer than in animals such as rats.
“We started by focusing on the large peripheral nerves as it seems the best target and, once we have mastered that, we would be able to move on to the spinal chord. This worked better than we anticipated so we are really pleased it is something we can take to humans in the not-too-distant future.”
In conjunction with ARC Centre of Excellence for Electromaterials Science in Wollongong, the St Vincent’s team built a chamber made of polymer and containing a gel of growth factors, which is placed in a 1cm section of missing nerve to act as a bridge and restore contact between the brain and damaged sections of the body.
In recent trials the scientists were able to see rats regain partial and, when the chambers were removed after four weeks, discovered new nerves had grown to reconnect the disabled limbs to the brain.
Assoc Prof Robert Kapsa said the technology could mitigate the impact of injuries by restoring more feeling.
Go deeper with Bing News on:
- Best Nerve Pain Supplements – Review Top Neuropathy Relief Productson August 20, 2021 at 10:32 am
Have you been diagnosed with neuropathy? This condition can cause extreme discomfort, leaving you debilitated due to pain and inflammation.
- Nerve Renew Reviews: Does It Work? Find Out the Truthon August 13, 2021 at 3:26 pm
Nerve-related issues are growing at a rapid pace globally, especially within developed nations where people are drifting towards more sedentary modes of living on a near-annual basis. Neuropathy, in ...
- DGIST selected for “Multidisciplinary Research Projects for Scientific Challenges 2021”on August 12, 2021 at 2:11 pm
The Targeted Neuronal Network Regeneration research group, DGIST, was selected for “Multidisciplinary Research Projects of Scientific Challenges 2021” by the Ministry of Science and ICT. The selected ...
- Subthreshold Electrical Stimulation Aims to Aid Stroke Rehabon August 12, 2021 at 1:10 pm
Researchers from the Daegu Gyeongbuk Institute of Science and Technology have developed a new, energy-efficient method of electrical brain stimulation that they suggest could aid stroke rehabilitation ...
- What is Dry AMD, and How is Lineage Cell Therapeutics Changing the Game?on August 12, 2021 at 7:56 am
When the macula — the small central portion of the retina — wears down, the light-sensing nerve tissue at the back of the eye ... cells will thin out and eventually die off. They do not regenerate.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Regenerative Medicine Market Revenue, Demand, Share, Size, Analysis and Research Report 2027 Says Reports And Dataon August 18, 2021 at 3:21 pm
The global regenerative medicine market is forecasted to reach a market size of USD 23.57 Billion by 2027, and register a significantly rapid revenue growth rate, according to a new report by Reports ...
- QC Kinetix Regenerative Medicine Clinic Ranks No. 62 on the 2021 Inc. 5000on August 18, 2021 at 1:30 pm
Inc. magazine revealed that QC Kinetix is No. 62 on its annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing ...
- Global Regenerative Medicine Markets, 2021-2029: Focus on Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologicson August 18, 2021 at 9:45 am
The "Global Regenerative Medicine Market Outlook 2029" report has been added to ResearchAndMarkets.com's offering. The market, which ...
- Global Cell & Gene Therapy Sector on Pace for Annual Records in Product Approvals and Financings, Says Alliance for Regenerative Medicineon August 18, 2021 at 6:44 am
Report Chronicles ‘A Year of Firsts’ For The Regenerative Medicine Sector Washington, DC, Aug. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The regenerative medicine and advanced therapies sector ...
- Regenerative medicine nears banner year with $14.1B cash infusion, regulatory milestones and a well-stocked pipelineon August 18, 2021 at 6:00 am
For a long time, gene and cell therapies were a treatment option for the future. Now, the pace of development is moving at breakneck speed, with a number of firsts and $14.4 billion in financing ...